Cefotetan versus clindamycin/tobramycin association in mixed aero-anaerobic peritonitis in rats.
Nardone
A
A
Institute of Emergency Surgery, University of Milan, Italy.
Nespoli
A
A
Padalino
P
P
Marradi
C
C
D000209:Acute-Phase Proteins / Q000096:biosynthesis; D000818:Animals; D001442:Bacteroides Infections / Q000188:drug therapy*; D015313:Cefotetan / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D014031:Tobramycin / Q000627:therapeutic use*
D000209:Acute-Phase Proteins; D011506:Proteins; D002981:Clindamycin; D015313:Cefotetan; D014031:Tobramycin